希少がんデータブック　ウェブサイト

関連文献

1. Sugiyama, H., et al., Increased incidence of rare cancers and varied age distributions by cancer group: A population-based cancer registry study in Hiroshima Prefecture, Japan. Cancer Epidemiol, 2023. 83: p. 102336.
2. Mailankody, S., et al., Epidemiology of rare cancers in India and South Asian countries – remembering the forgotten. Lancet Reg Health Southeast Asia, 2023. 12: p. 100168.
3. Gatta, G., R. Capocaccia, and L. Botta, Descriptive epidemiology of the head and neck cancers in old patients. Front Oncol, 2023. 13: p. 1102236.
4. Dasgupta, P., et al., Geographical and spatial disparities in the incidence and survival of rare cancers in Australia. Int J Cancer, 2023. 152(8): p. 1601-1612.
5. Buchalet, C. and C. Durdux, Role of radiotherapy in the management of rare solid thoracic tumors of the adults. Cancer Radiother, 2023. 27(6-7): p. 614-621.
6. Botta, L., et al., Head and neck cancers survival in Europe, Taiwan, and Japan: results from RARECAREnet Asia based on a privacy-preserving federated infrastructure. Front Oncol, 2023. 13: p. 1219111.
7. Salmeron, D., et al., Estimating Country-Specific Incidence Rates of Rare Cancers: Comparative Performance Analysis of Modeling Approaches Using European Cancer Registry Data. Am J Epidemiol, 2022. 191(3): p. 487-498.
8. Salmeron, D., et al., Salmeron et al. Respond to “Future Directions for Predicting Rare Cancer Rates”. Am J Epidemiol, 2022. 191(3): p. 503-504.
9. van Rees, J.M., et al., The incidence, treatment and survival of patients with rare types of rectal malignancies in the Netherlands: A population-based study between 1989 and 2018. Eur J Cancer, 2021. 152: p. 183-192.
10. Stiller, C.A., et al., Kaposi sarcoma incidence, survival and trends: Data from the information network on rare cancers in Europe (RARECAREnet). Cancer Epidemiol, 2021. 70: p. 101877.
11. Stacchiotti, S., et al., Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities. Cancer, 2021. 127(16): p. 2934-2942.
12. Bilkey, G.A., et al., Descriptive epidemiological study of rare, less common and common cancers in Western Australia. BMC Cancer, 2021. 21(1): p. 779.
13. Wright, C.M., et al., Sarcoma epidemiology and cancer-related hospitalisation in Western Australia from 1982 to 2016: a descriptive study using linked administrative data. BMC Cancer, 2020. 20(1): p. 625.
14. Virgili, G., et al., Incidence and Survival of Patients With Conjunctival Melanoma in Europe. JAMA Ophthalmol, 2020. 138(6): p. 601-608.
15. Matsuda, T., et al., Rare cancers are not rare in Asia as well: The rare cancer burden in East Asia. Cancer Epidemiol, 2020. 67: p. 101702.
16. Locati, L., et al., Rare thyroid malignancies in Europe: Data from the information network on rare cancers in Europe (RARECAREnet). Oral Oncol, 2020. 108: p. 104766.
17. Casali, P.G. and A. Trama, Rationale of the rare cancer list: a consensus paper from the Joint Action on Rare Cancers (JARC) of the European Union (EU). ESMO Open, 2020. 5(2).
18. Botta, L., et al., Incidence and survival of rare cancers in the US and Europe. Cancer Med, 2020. 9(15): p. 5632-5642.
19. Trama, A., et al., Quality of Care Indicators for Head and Neck Cancers: The Experience of the European Project RARECAREnet. Front Oncol, 2019. 9: p. 837.
20. Trama, A., et al., Is the cancer survival improvement in European and American adolescent and young adults still lagging behind that in children? Pediatr Blood Cancer, 2019. 66(1): p. e27407.
21. Ray-Coquard, I., et al., Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting. Eur J Surg Oncol, 2019. 45(1): p. 67-74.
22. Pasquali, S., et al., Treatment challenges in and outside a network setting: Soft tissue sarcomas. Eur J Surg Oncol, 2019. 45(1): p. 31-39.
23. Orlandi, E., et al., Treatment challenges in and outside a network setting: Head and neck cancers. Eur J Surg Oncol, 2019. 45(1): p. 40-45.
24. Nicolai, N., et al., Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference. Eur J Surg Oncol, 2019. 45(1): p. 60-66.
25. Lykoudis, P.M., et al., Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours. Eur J Surg Oncol, 2019. 45(1): p. 46-51.
26. Imbimbo, M., et al., Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting. Eur J Surg Oncol, 2019. 45(1): p. 75-80.
27. Gatta, G., et al., Epidemiology of rare cancers and inequalities in oncologic outcomes. Eur J Surg Oncol, 2019. 45(1): p. 3-11.
28. Ferrari, A., et al., Defining and listing very rare cancers of paediatric age: consensus of the Joint Action on Rare Cancers in cooperation with the European Cooperative Study Group for Pediatric Rare Tumors. Eur J Cancer, 2019. 110: p. 120-126.
29. Dinmohamed, A.G. and O. Visser, Incidence of acute promyelocytic leukemia across Europe: results of RARECAREnet-a population-based study. Stem Cell Investig, 2019. 6: p. 37.
30. Bustamante-Teixeira, M.T., et al., Incidence of rare cancers in the city of Sao Paulo, Brazil. Tumori, 2019. 105(1): p. 22-30.
31. van der Zwan, J.M., et al., Rare cancers in The Netherlands: a population-based study. Eur J Cancer Prev, 2018. 27(4): p. 384-390.
32. Ressing, M., et al., Strengthening health data on a rare and heterogeneous disease: sarcoma incidence and histological subtypes in Germany. BMC Public Health, 2018. 18(1): p. 235.
33. Pusceddu, S., et al., A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors. Endocr Relat Cancer, 2018. 25(6): p. 607-618.
34. Botta, L., et al., Bayesian estimates of the incidence of rare cancers in Europe. Cancer Epidemiol, 2018. 54: p. 95-100.
35. Bergerot, C.D., et al., Assessment of distress and quality of life in rare cancers. Psychooncology, 2018. 27(12): p. 2740-2746.
36. Trama, A., et al., Data quality in rare cancers registration: the report of the RARECARE data quality study. Tumori, 2017. 103(1): p. 22-32.
37. Gatta, G., et al., Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study. Lancet Oncol, 2017. 18(8): p. 1022-1039.
38. Ferrari, A., et al., Access to clinical trials for adolescents with soft tissue sarcomas: Enrollment in European pediatric Soft tissue sarcoma Study Group (EpSSG) protocols. Pediatr Blood Cancer, 2017. 64(6).
39. Group, A.W., et al., Italian cancer figures–Report 2015: The burden of rare cancers in Italy. Epidemiol Prev, 2016. 40(1 Suppl 2): p. 1-120.
40. Coebergh, J.W., et al., EUROCOURSE lessons learned from and for population-based cancer registries in Europe and their programme owners: Improving performance by research programming for public health and clinical evaluation. Eur J Cancer, 2015. 51(9): p. 997-1017.
41. Tamaki, T., et al., The burden of rare cancer in Japan: application of the RARECARE definition. Cancer Epidemiol, 2014. 38(5): p. 490-5.
42. Stiller, C.A., et al., Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project. Cancer Epidemiol, 2014. 38(6): p. 670-8.
43. van der Zwan, J.M., et al., Rare neuroendocrine tumours: results of the surveillance of rare cancers in Europe project. Eur J Cancer, 2013. 49(11): p. 2565-78.
44. Stiller, C.A., et al., Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project. Eur J Cancer, 2013. 49(3): p. 684-95.
45. Mallone, S., et al., Methodological aspects of estimating rare cancer prevalence in Europe: the experience of the RARECARE project. Cancer Epidemiol, 2013. 37(6): p. 850-6.
46. Visser, O., et al., Incidence, survival and prevalence of myeloid malignancies in Europe. Eur J Cancer, 2012. 48(17): p. 3257-66.
47. van der Zwan, J.M., et al., Invasive extramammary Paget’s disease and the risk for secondary tumours in Europe. Eur J Surg Oncol, 2012. 38(3): p. 214-21.
48. van der Zwan, J.M., et al., Carcinoma of endocrine organs: results of the RARECARE project. Eur J Cancer, 2012. 48(13): p. 1923-31.
49. Trama, A., et al., The burden of rare cancers in Italy: the surveillance of rare cancers in Italy (RITA) project. Tumori, 2012. 98(5): p. 550-8.
50. Siesling, S., et al., Rare thoracic cancers, including peritoneum mesothelioma. Eur J Cancer, 2012. 48(7): p. 949-60.
51. Gatta, G., et al., Embryonal cancers in Europe. Eur J Cancer, 2012. 48(10): p. 1425-33.

更新日：2023年12月21日